Aligos Therapeutics (ALGS) Return on Sales [ROS] (2019 - 2026)
Aligos Therapeutics (ALGS) posted Return on Sales [ROS] of -773.50% for Q3 2026, up 3053.90 percentage points from -3827.40% a year earlier and up 1338.64 percentage points from the prior quarter.
Aligos Therapeutics (ALGS) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Aligos Therapeutics was -1244.18%, up 2062.50 percentage points year-over-year; for FY2025, it was -4024.93%, down 1555.98 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for three consecutive years, though with a five-year change of +3126.68 percentage points (FY2020 to FY2025).
- In prior years, Aligos Therapeutics' Return on Sales [ROS] was -2468.96% in FY2024 (-1525.21 pp), -943.75% in FY2023 (-242.08 pp), -701.66% in FY2022 (+2242.16 pp) and -2943.82% in FY2021 (+4207.79 pp).
- The Q3 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q2 2023.
- On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -1021.77 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 9698.78 percentage points; the weakest was Q4 2025, with a drop of 9514.46 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -2112.14% (Q2 2026), -951.55% (Q1 2026) and -12907.69% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | -773.50% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -773.50% |
| Jun 30, 2026 | -2,112.14% |
| Mar 31, 2026 | -951.55% |
| Dec 31, 2025 | -12,907.69% |
| Sep 30, 2025 | -3,827.40% |
| Jun 30, 2025 | -1,924.04% |
| Mar 31, 2025 | -6,187.46% |
| Dec 31, 2024 | -3,393.23% |
| Sep 30, 2024 | -1,610.48% |
| Jun 30, 2024 | -2,489.54% |
| Mar 31, 2024 | -3,176.66% |
| Dec 31, 2023 | -1,294.03% |
| Sep 30, 2023 | -885.38% |
| Jun 30, 2023 | -445.76% |
| Mar 31, 2023 | -925.98% |
| Dec 31, 2022 | -641.28% |
| Sep 30, 2022 | -461.47% |
| Jun 30, 2022 | -552.21% |
| Mar 31, 2022 | -1,383.00% |
| Dec 31, 2021 | -10,340.05% |
Aligos Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();